Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai; President for Academic Affairs, Mount Sinai Health System
Dennis Charney is a world-renowned researcher and transformation leader who, through his commitment to innovation and science, has led the Icahn School of Medicine at Mount Sinai to unparalleled growth and high national rankings. He is a former Yale psychiatry professor and researcher at the National Institute of Mental Health, where he oversaw the Mood and Anxiety Disorder Research Program. Charney’s work demonstrating ketamine as a rapidly acting antidepressant was hailed as one of the most exciting developments in antidepressant therapy in decades. He’s written more than 700 publications and co-authored Resilience: The Science of Mastering Life’s Greatest Challenges.